Search results
Showing 8051 to 8100 of 8118 results
Test people with womb cancer for inherited genetic condition, NICE says in new guidance
Research led by Professor Emma Crosbie, with Professor Gareth Evans and Dr Neil Ryan from The University of Manchester and Manchester University NHS Foundation Trust, showed the benefits of different testing strategies for Lynch syndrome in womb cancer cases in increasing diagnosis of the condition.
Thousands of breast cancer patients to have routine access to NICE-approved drug combination
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available for routine use after draft guidance from NICE today (26 February) recommended ribociclib (also called Kisqali and made by Novartis) is taken out of the Cancer Drugs Fund (CDF).
Thousands of lung cancer patients to benefit from life-extending treatment
A potentially life-extending treatment for some people with non-squamous, non-small-cell lung cancer (NSCLC) will now be available on the NHS following its approval by NICE in draft guidance published today.
Thousands of men with enlarged prostates could be helped by new NICE guidance on laser device
Laser treatment recommended in new NICE guidance could benefit more than 13,000 men with a benign enlarged prostate.
NICE recommends faricimab as treatment option for adults with wet age-related macular degeneration or diabetic macular oedema
Thousands of people set to benefit from first new treatment for osteoporosis for over a decade
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published today (Friday 1 April) by NICE.
More than 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their condition and at the same time reduce the need for finger prick testing by up to 50%, following new advice from NICE.
Steam treatment recommended for men with an enlarged prostate
Minimally invasive procedure involves injecting steam to destroy excess prostate tissue
New Strensiq deal paves way for NICE approval of life saving drug
An agreement has been reached that means more people with a rare life threatening disease can be offered an innovative new drug.
Strategic collaboration announced by NICE and Health Technology Wales
Collaboration outlines the strategic planning and delivery of independent and authoritative medical technology guidance
Targeted treatment for rare form of aggressive lung cancer gets NICE approval
Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer
Tighter blood glucose targets for people with type 1 diabetes
New diabetes guidance includes tighter targets for blood sugar levels to help reduce variation in the management and care of condition.
NICE is developing two new guidelines to help tackle the growing threat of antibiotic resistance.
Test children's urine before prescribing antibiotics for UTIs, says NICE
NICE is advising healthcare professionals use dipstick urine tests to decide whether to give children antibiotics for suspected urinary tract infections (UTI).
How is NICE supporting digital health technology developers?
Richard Chivers, operations manager for NICE Scientific Advice, looks at how we’re supporting digital health technology developers and helping them with some of the challenges around evidence requirements and adoption within the NHS.
How my experience as a patient helped shape NICE guidelines for colorectal cancer
Following my surgery and treatment for colorectal cancer in 2014, I wanted to contribute to research in the cancer field and hopefully improve things for patients in the future, so I applied and was accepted to be a lay member for NICE’s colorectal cancer guideline committee.
How NICE guidance and resources can be used to evidence continuing professional development (CPD)
Registered social workers must demonstrate the use of evidence and research to inform their practice in order to meet professional standards. This is echoed in Social Work England’s continuing professional development (CPD) standards.
How NICE is helping to build the role of the NHS on the global stage
Kevin Miles discusses how NICE International is working to shape and improve health and care systems at home and abroad as part of the NHS Consortium for Global Health.
Working at the forefront of neurodegenerative disease research
Claire Hawksworth reveals NICE’s role in a global partnership to better understand neurodegenerative conditions and speed up delivery of innovative treatments.
Working in partnership to harness the potential of digital technology
Nicola Bent talks about NICE and the AHSN Network’s important ambition to address market access challenges for digital innovation as part of the collaboration agreement
Nick discusses World Antimicrobial Awareness Week and an important project he’s involved with to develop new models for the evaluation and purchase of antimicrobials.
World Evidence-Based Healthcare Day: Using evidence to inform our recommendations
Dr Martin Allaby discusses World Evidence-Based Healthcare Day and how NICE uses evidence to inform our recommendations.
Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of HTAi 2021 in the UK
Draft guidance released for consultation today (Friday 4th Nov) states the technologies can be used with support from a mental health professional, while further evidence is generated to check if the benefits they offer are realised in practice.
Behind the Headlines - Prostate cancer drug decision a 'cruel twist'
We take a closer look at media coverage that claims our prostate cancer drug decision is a 'cruel twist' for patients.
NICE recommends adapted shoes for people with severe osteoarthritis
People with osteoarthritis who are eligible for knee surgery could be offered specially adapted shoes to help with their painful and stiff knees following a draft recommendation by NICE.
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
NICE is advising doctors, nurses and pharmacists to discuss with patients the risks of prescribing them medicines including opioids, sleeping pills and antidepressants.
Explore data about our technology appraisal guidance. Find out about the decisions we make and our ways of working.
NICE and partners announce this year's theme for World Evidence-Based Healthcare Day
Global alliance to shine spotlight on evidence-based healthcare on Wednesday 20th October
Sign up for our newsletters and alerts Keeping you up to date with important developments at NICE. Sign up for newsletters and alerts
NICE welcomes Professor Bee Wee CBE as new non-executive director
New NICE non-executive director appointment approved by Sajid Javid MP, the Secretary of State for Health and Social Care
NICE's Interventional Procedures Advisory Committee chairman awarded MBE by Queen
Professor Tom Clutton-Brock has been involved with NICE’s work for more than a decade
Tributes paid following the death of founding NICE chairman Professor Sir Mike Rawlins
As founding chairman of NICE, Sir Mike led NICE from 1999 to 2013, through its early formative years to its current position as a world leader in health and social care guidance and medicine evaluation.
Online event will lift the lid on how the two organisations worked together during the pandemic
Better research, faster: NIHR launch new funding call to address NICE research recommendations
In April 2021, the National Institute for Health Research (NIHR) launched a new rolling funding call for studies addressing NICE research recommendations.
Shared decision making recommendations will ensure people are at the heart of healthcare
NICE’s new guideline on shared decision making will help transform people’s experiences of health and social care. It will instil greater collaboration between professionals, patients and their families. It will pioneer a new climate and culture of putting people firmly at the heart of our healthcare system.
Toby Lasserson, deputy editor in chief at Cochrane, writes about a new collaborative agreement with NICE, how it will work and what it means for the health service
NICE is making changes to simplify our offer to the life sciences industry
Speaking with one language: How using a common data model might speed up decision making
NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.
Starting with the end in mind - the Innovative Licensing and Access Pathway
Launched in January, the new Innovative Licensing and Access Pathway (ILAP) will smooth the process by which innovative new medicines are developed, speeding their progression from clinical trial through to the NHS. It is an exciting development that signals greater collaboration between the agencies involved and, we hope, should bring significant benefits to patients.
Jeanette Kusel explains how we are working in partnership to improve patient access to the best digital health innovations.
NICE has launched a free learning course that provides an introduction to health technology assessment (HTA).
"Tell me and I forget. Teach me and I remember. Involve me and I learn." Benjamin Franklin
Time to talk: about NICE's latest depression guidelines and quality standard work
To mark Time to Talk Day (February 2) we spoke with Catherine Ruane, who acted as a carer for her father and sister, who both lived with depression.
Towards a new partnership – NICE and the voluntary and community sector
Victoria Thomas gives details of NICE’s new voluntary and community sector forum, which brings together a range of organisations, including health and care sector charities and not for profit groups, and gives them an opportunity to share their views and help shape NICE’s work in the future
As we launch an early version of the online service, mapping out the regulatory and health technology assessment pathway, Ciara Cook invites future users to help shape this exciting new initiative.
Dr Angela Houston, Consultant in Infection, discusses ways that St George’s University Hospitals have been tackling tuberculosis.
As London counts down to the 2012 Olympics, experts call for more to be done to encourage people to be physically active
As NICE publishes its 300th technology appraisal, we look back at the impact they have had on patient care.